Dir
Thompson Peter A., M.D. is a Person and a seasoned biopharmaceutical executive and investor who serves as a Director at Sionna Therapeutics, Inc. (SION).[[4]](https://www.sionnatx.com/about-us/) A board-certified internist and oncologist, he is an Affiliate Professor of Neurosurgery at the University of Washington and a Member at OrbiMed Advisors LLC, where he has held senior roles since 2010.[[4]](https://www.sionnatx.com/about-us/)[[5]](https://ars-pharma.com/peter-a-thompson-md/) At Sionna, he brings more than three decades of industry leadership to the board, drawing on prior executive experience at Becton, Dickinson and Company, Chiron Corporation, and Trubion Pharmaceuticals, Inc., as well as extensive service on the boards of public and private biopharmaceutical companies.[[4]](https://www.sionnatx.com/about-us/)[[5]](https://ars-pharma.com/peter-a-thompson-md/)
Dr. Thompson is recognized as an Ernst & Young Entrepreneur of the Year awardee and an inventor on numerous patents, reflecting his impact across drug development and biotechnology entrepreneurship.[[4]](https://www.sionnatx.com/about-us/)[[5]](https://ars-pharma.com/peter-a-thompson-md/) He has co-founded and led multiple therapeutics companies, including Trubion Pharmaceuticals, Silverback Therapeutics, Corvus Pharmaceuticals, Cleave Biosciences, Edgewise Therapeutics, and Terremoto BioSciences, and currently serves on the boards of ARS Pharmaceuticals Inc., Corvus Pharmaceuticals, Inc., Edgewise Therapeutics, Inc., Alpine Immune Sciences Inc., and other life sciences companies.[[3]](https://terremotobio.com/team/peter-thompson/)[[5]](https://ars-pharma.com/peter-a-thompson-md/)[[6]](https://edgewisetx.com/team/peter-thompson-m-d/)[[8]](https://investors.januxrx.com/investor-media/governance/board-of-directors/person-details/default.aspx?ItemId=d6d68a44-38ee-45fe-926f-32a0e6bc573f) Earlier in his career, he served on the staff of the National Cancer Institute following his medical training. He holds a Sc.B. in Molecular Biology and Mathematics and an M.D. from Brown University Medical School, combining scientific, clinical, and financial expertise in his role as a corporate insider and director.[[4]](https://www.sionnatx.com/about-us/)[[5]](https://ars-pharma.com/peter-a-thompson-md/)
View full insider profile →
Discussion